ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced the ...

We finally have the technology, infrastructure, and the political will to end the US HIV epidemic, write the Brown University doctors who lead the Rhode Island Public Health Institute. But access to ...

A recent study of injectable pre-exposure prophylaxis found that twice-yearly injections of lenacapavir — marketed as Yeztugo by Gilead Sciences — do not have clinically significant interactions with ...

CVS Health, which runs the nation’s largest pharmacy benefit manager, will not cover Gilead Sciences’ FDA-approved HIV prevention drug Yeztugo, also known as lenacapavir, an injectable form of PrEP ...

LOS ANGELES--(BUSINESS WIRE)--In light of the recently announced plan to put 2.5 million people on injectable pre-exposure prophylaxis (PrEP), specifically lenacapavir, by 2027, AIDS Healthcare ...

Findings showed 99.9% of participants in the lenacapavir group did not acquire HIV infection. Twice-yearly lenacapavir was found to be superior to daily emtricitabine 200mg and tenofovir disoproxil ...

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden administration announced October 21. The news comes just weeks after it was announced ...

Patients are already receiving the new PrEP injectable option lenacapavir in the Bay Area, though issues with insurance are complicating the process of getting shots. The new injectable was approved ...

Patients can now receive long acting injectables to advance closing the gap in HIV prevention. In a major step toward HIV prevention, CAN Community Health, the nation’s leading resource in ending ...

Add Yahoo as a preferred source to see more of our stories on Google. Close up barefoot young gay male couple in pajamas cuddling on bed in morning I haven't taken my pills in two weeks. I went to my ...

The Biden-Harris administration announced Monday a new requirement for insurance providers to cover injectable PrEP in their policies without a co-payment for consumers. The new rule, built on ...

A nurse at Tudor Sub-County Hospital in Mombasa administers Lenacapavir injection during the rollout of the vaccine on March 13, 2026. [Robert Menza, Standard] Mombasa County has officially rolled out ...